Virax Biolabs Group Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-06-30 | 2023-09-30 | 2023-03-31 |
|---|---|---|---|
Revenue | $79 | $76 | $2 |
Gross Profit | 40 | 10 | -1 |
EBITDA | -3,722 | -2,688 | -4,292 |
EBIT | -3,808 | -2,706 | -8,584 |
Net Income | -3,823 | -2,909 | -4,013 |
Net Change In Cash | 79 | 76 | 2 |
Free Cash Flow | -3,249 | -4,165 | -2,061 |
Cash | 3,589 | 5,107 | 9,352 |
Basic Shares | 2,237 | 1,775 | 1,554 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $156 | $8 | $0 | $123 |
Gross Profit | 50 | -1 | 0 | -9 |
EBITDA | -6,609 | -5,442 | -644 | |
EBIT | -6,712 | -5,442 | -1,734 | -1,289 |
Net Income | -6,733 | -5,457 | -1,708 | -650 |
Net Change In Cash | 156 | 8 | 0 | 123 |
Free Cash Flow | -7,411 | -4,358 | -809 | -590 |
Cash | 3,589 | 9,352 | 21 | 17 |
Basic Shares | 2,006 | 1,062 | 1,137 | 1,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-06-30 | -$0.03 |
